ArticleNeuro-oncology advances

POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with

Alexander M Menzies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.